Since arriving at the University in 2010, the president has contributed to and overseen a rich variety of advancements that ...

USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur ...

The future of health care is being rewritten right now. Artificial intelligence (AI), digital therapeutics and game-changing ...

The conference was born out of a partnership with the Children’s Hospital of Philadelphia. In partnership with the Children’s ...

Silexion Therapeutics Corp. ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced significant new findings from ...

In terms of valuation, Summit Therapeutics Inc’s market capitalization stands at $15.87 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

Maky Zanganeh, Co-CEO of Summit Therapeutics' owns 5% of the biopharmaceutical company and stock options. One of the 34 ...

Mark Barrett is the co-founder and CEO of pharma company APC. He spoke to SiliconRepublic.com about the company’s journey.

Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...